SANOFI-AVENTIS (EPA:SAN)

PRESS RELEASE

published on 02/17/2026 at 12:00, 5 months 13 days ago

Press Release: Sanofi and Teva’s duvakitug phase 2b maintenance data demonstrated clinically meaningful durable efficacy in ulcerative colitis and Crohn’s disease
Sanofi and Teva's duvakitug phase 2b maintenance data show durable efficacy in ulcerative colitis and Crohn's disease. Results reinforce ongoing phase 3 programs in UC and CD

Ulcerative Colitis Sanofi Teva Crohn's Disease Duvakitug
BRIEF

published on 02/16/2026 at 07:05, 5 months 15 days ago

Beyfortus Shows Extended Benefits for Infants Against RSV

Infant Health Beyfortus Hospitalization Reduction RSV Immunization NIRSE-GAL Study
BRIEF

published on 02/16/2026 at 07:05, 5 months 15 days ago

Beyfortus prouve son efficacité au-delà de la première saison du VRS

Sanofi VRS Beyfortus Nourrissons Immunisation
BRIEF

published on 02/16/2026 at 07:05, 5 months 15 days ago

Beyfortus proves its effectiveness beyond the first season of VRS

Sanofi VRS Beyfortus Infants Immunization
BRIEF

published on 02/16/2026 at 07:05, 5 months 15 days ago

Beyfortus présente des bénéfices prolongés chez les nourrissons contre le VRS

Beyfortus Réduction Des Hospitalisations Santé Infantile Vaccination Contre Le VRS Étude NIRSE-GAL
PRESS RELEASE

published on 02/16/2026 at 07:00, 5 months 15 days ago

Press Release: Beyfortus study published in The Lancet Infectious Diseases shows benefit for infants beyond first RSV season
Universal RSV immunization with Beyfortus reduces hospitalizations in infants across two seasons, as per study in The Lancet Infectious Diseases and RSVVW '26 conference findings

RSV Beyfortus Infants Immunization Hospitalizations
PRESS RELEASE

published on 02/16/2026 at 07:00, 5 months 15 days ago

Communiqué de presse : L’étude sur Beyfortus publiée dans la revue The Lancet Infectious Diseases montre ses bénéfices chez les nourrissons au-delà de la première saison du VRS
Étude sur Beyfortus montrant réduction significative des hospitalisations liées au VRS chez les nourrissons. Résultats présentés dans The Lancet Infectious Diseases et à la conférence 2026 de la Semaine du vaccin contre le VRS

VRS Étude Beyfortus Nourrissons Hospitalisations
BRIEF

published on 02/10/2026 at 15:05, 5 months 20 days ago

Sanofi Finalizes Acquisition of Dynavax

Acquisition Biopharma Sanofi Vaccines Dynavax
BRIEF

published on 02/10/2026 at 15:05, 5 months 20 days ago

Sanofi finalise l'acquisition de Dynavax

Acquisition Biopharma Sanofi Vaccins Dynavax
PRESS RELEASE

published on 02/10/2026 at 15:00, 5 months 20 days ago

Press Release: Sanofi completes the acquisition of Dynavax
Sanofi completes acquisition of Dynavax, bolstering presence in adult immunization with HEPLISAV-B vaccine and Z-1018 shingles vaccine candidate, enhancing global reach and development capabilities

Acquisition Sanofi Vaccine Immunization Dynavax

Published on 08/01/2026 at 01:58, 2 days 7 hours ago

Clôture de l'option sur la propriété de graphite au Québec
Published on 08/01/2026 at 01:20, 2 days 7 hours ago

Gamma Resources Announces $880,000 Private Placement with Full Warrant Coverage
Published on 08/01/2026 at 01:15, 2 days 7 hours ago

Clean Air Metals and Fiore-Backed Springbok Ventures Announce Strategic Business Combination
Published on 08/01/2026 at 00:30, 2 days 8 hours ago

Battery X Metals Announces Amendment to Corporate Awareness Engagement
Published on 08/01/2026 at 00:25, 2 days 8 hours ago

BioNxt Solutions Announces Option Grants

View all ACCESSWIRE

Published on 08/03/2026 at 08:30, 31 minutes ago

MOH Nippon Plc - Suspension
Published on 08/03/2026 at 08:30, 31 minutes ago

GS Chain plc - Restoration
Published on 08/03/2026 at 08:30, 31 minutes ago

Suspension - The Hospital Company (Dartford) Issuer PLC
Published on 08/03/2026 at 08:15, 46 minutes ago

CPI PROPERTY GROUP – Summer Update
Published on 08/03/2026 at 08:00, 1 hour 1 minute ago

Transaction in Own Shares

View all EQS

Published on 08/03/2026 at 08:29, 32 minutes ago

Launch of a €225 million tranche of its share buyback programme
Published on 08/03/2026 at 08:29, 32 minutes ago

Lancement d’une tranche de 225 millions d’euros du programme de rachat d’actions
Published on 08/03/2026 at 07:00, 2 hours 1 minute ago

BIOPHYTIS PROVIDES AN UPDATE AND SHARE STRATEGIC DRIVERS SUPPORTING ITS HONG KONG JOINT VENTURE
Published on 08/03/2026 at 07:00, 2 hours 1 minute ago

Biophytis fait un point d’étape et partage les perspectives de sa co-entreprise à Hong Kong
Published on 07/31/2026 at 21:00, 2 days 12 hours ago

Carrefour finalise la vente de sa participation minoritaire dans CarrefourSA en Turquie à Yeni Mağazacılık A.Ş., société opérant l'enseigne de A101 et contrôlée par le Groupe Aydın

View all LES ECHOS COMFI WIRE

News